成人先天性心脏病心脏移植的趋势与结局
基于美国器官共享联合网络数据库,纳入2737例listed成人先天性心脏病心脏移植患者,按4个时代比较实践与结局。listed和移植患者逐渐增加,机械支持及同期肝肾移植显著增加;listed后delisted/死亡比例及等待时间下降(P=0.01),30天移植后死亡率仍高但era 3起显著改善(P=0.01)。当前1年和5年生存率分别为85%和65%。
要点
- listed和移植患者逐渐增加,机械支持及同期肝肾移植显著增加
- listed后delisted/死亡比例及等待时间下降(P=0.01),era 4尤为明显
- 30天移植后死亡率仍高,但era 3起显著改善(P=0.01);1年和5年生存率分别为85%和65%
核心结论
- 成人先天性心脏病心脏移植不断增加,复杂性增加,移植前机械支持和同期器官移植使用率更高,但更复杂的患者并未经历更差的结局。
- 早期死亡率改善但仍高;新供体分配系统允许更短等待时间和更高移植比例,而未改变早期死亡率。
研究设计与样本
- 回顾性队列研究,数据来自美国器官共享联合网络数据库,纳入2737例listed成人先天性心脏病心脏移植患者。
- 按4个时代分组:era 1-3为1992年至2018年间大致相等的三个时期,era 4为2018年后对应新分配系统;进行单因素和多因素分析评估结局。
主要发现
- listed和移植患者逐渐增加,机械支持及同期肾脏和肝脏移植显著增加。
- 移植比例保持不变,但listed后delisted/死亡比例下降(P=0.01),等待时间下降(P=0.01),尤其在era 4。
- 30天移植后死亡率仍高,但era 3起显著改善(P=0.01)。
- 当前1年生存率为85%,5年生存率为65%,改善主要与早期死亡减少相关。
- 多因素分析中,与生存相关的因素包括较低肾小球滤过率(HR=0.99,P=0.042)、胆红素(HR=1.17,P<0.001)和机械通气(HR=2.3,P=0.004)。
关键数值与推荐
- listed后delisted/死亡比例下降(P=0.01),等待时间下降(P=0.01)。
- 30天移植后死亡率从era 3起显著改善(P=0.01)。
- 当前1年生存率85%,5年生存率65%。
- 多因素分析:肾小球滤过率HR=0.99(P=0.042),胆红素HR=1.17(P<0.001),机械通气HR=2.3(P=0.004)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Heart transplantation for adult congenital heart disease is complicated and associated with challenging pretransplant support, long waiting and high early post-transplant mortality. We explored if surgical and medical advances and allocation system changes have affected outcomes. METHODS: From United Network for Organ Sharing database, adults with congenital heart disease listed for heart transplantation were queried. To explore practice and outcome trends, patients were divided into 4 eras (eras 1-3: nearly 3 equal periods from 1992 to 2018, era 4: after 2018, corresponding with new allocation system). Univariate and multivariable analysis was performed to evaluate outcomes. RESULTS: A total of 2737 patients were listed. There was gradual increase in listed and transplanted patients, along with significant increase in use of mechanical support, simultaneous kidney and liver transplantation. While proportion of transplanted remained constant, there was decrease in proportion delisted/died after listing (P = 0.01) and waiting list duration (P = 0.01), especially in era 4. Thirty-day post-transplant mortality remains high; however, it has significantly improved starting era 3 (P = 0.01). Current survival at 1-year and 5-years is 85% and 65%, with improvement mainly related to decreased early death. On multivariable analysis, factors associated with survival were lower glomerular filtration rate (hazard ratio = 0.99, P = 0.042), bilirubin (hazard ratio = 1.17, P<0.001) and mechanical ventilation (hazard ratio = 2.3, P=0.004). CONCLUSIONS: Heart transplantation in adults with congenital heart disease is increasing, along with added complexity, higher usage of pretransplant mechanical support and simultaneous organ transplantation. Despite that, more complex patients do not experience worse outcomes. Early mortality improved but remains high. New donor allocation system allowed shorter waiting time and higher proportion transplanted without altering early mortality.
引用
- Alsoufi B, Kozik D, Perrotta M, et al. Trends and outcomes of heart transplantation in adults with congenital heart disease. Eur J Cardiothorac Surg. 2024. PMID: 38447194. doi:10.1093/ejcts/ezae086
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。